Release Date: Aug 2017
CC: PC, MK, PBL, SBP
Jennifer L. Sauter, MD
Pathologist and Assistant Attending Pathologist, Memorial Sloan Kettering Cancer Center, New York, NY
Michael R. Henry, MD
Director of Cytopathology, Mayo Clinic, Rochester, MN
Fine needle aspiration (FNA) of the thyroid is a common specimen evaluated in the cytology laboratory. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has streamlined and standardized thyroid FNA terminology. Advances in thyroid cytology since the initial TBSRTC has led to preparation of a 2nd edition of TBSRTC. Indeterminate cytology diagnoses remain a challenging area of thyroid cytology. This course uses a case-based approach to illustrate strategies that participants can apply to their own practices to reduce their rates of atypical thyroid cytology reporting. We will touch on the use of molecular methods to assist in the perioperative management of thyroid nodules. We will also discuss the cytologic implications of the reclassification of encapsulated follicular variant of papillary thyroid carcinoma to noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and the modification of thyroid cytology reporting to reflect this change in classification. Knowledge of the basic fundamentals of thyroid cytology is assumed.
After attending this session, participants will be able to:
· Implement a multidisciplinary approach to thyroid cytology.
· Apply strategies to lower rates of atypical thyroid cytology diagnoses.
· Modify thyroid cytology reporting to reflect recent changes in terminology of thyroid lesions.
Who should attend? Practicing Pathologists, Residents, Cytotechnologists, Students